Evidence map›Paper›PMID 32729001›Full record

ArticleCell stress & chaperones2020

SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism.

Guglielmo Lucchese, Agnes Flöel

Open access · hybridAbstract read
In one paragraph

Article in Cell stress & chaperones, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. NETosis: A key player in autoimmunity, COVID-19, and long COVID.Journal of translational autoimmunity · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Guglielmo LuccheseDepartment of Neurology, Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Str, 17475, Greifswald, Germany. guglielmo.lucchese@uni-greifswald.de.ORCID 0000-0002-1809-6376
Agnes FlöelDepartment of Neurology, Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Str, 17475, Greifswald, Germany.
Universitätsmedizin Greifswald · DE

Funding

Deutsche Forschungsgemeinschaft 327654276 - SFB 1315
6 · The paper itself

Abstract

Severe acute respiratory syndrome-related coronavirus 2 infection has been associated with Guillain-Barré syndrome. We investigated here the potential mechanism underlying the virus-induced damage of the peripheral nervous systems by searching the viral amino acid sequence for peptides common to human autoantigens associated with immune-mediated polyneuropathies. Our results show molecular mimicry between the virus and human heat shock proteins 90 and 60, which are associated with Guillain-Barré syndrome and other autoimmune diseases. Crucially, the shared peptides are embedded in immunoreactive epitopes that have been experimentally validated in the human host.

Indexed as

Chaperonin 60HSP90 Heat-Shock ProteinsMitochondrial ProteinsViral ProteinsAmino Acid SequenceAutoantigensBetacoronavirusCoronavirus InfectionsCOVID-19Databases, ProteinGuillain-Barre SyndromeHumansImmunodominant EpitopesMolecular MimicryPandemicsPneumonia, ViralAutoantigensChaperonin 60HSP90AB1 protein, humanHSP90 Heat-Shock ProteinsHSPD1 protein, humanImmunodominant EpitopesMitochondrial ProteinsViral ProteinsCOVID-19DemyelinationNeuropathy

Identifiers

PMID32729001
PMCPMC7387880
OpenAlexW3045894551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.